期刊文献+

血清CA125水平与淋巴瘤细胞浸润及疗效的关系 被引量:1

Correlations between Serum CA125 Level and Infiltration of Lymphoma Cells and Response to Treatment in Patients with NHL
下载PDF
导出
摘要 目的探讨血清CA125与非霍奇金淋巴瘤(NHL)细胞浸润及患者疗效的关系。方法采用放射免疫学方法测定103例NHL患者的血清CA125水平,并结合临床特征进行分析。结果约49.5%(51/103)的NHL患者血清CA125增高;血清CA125水平与乳酸脱氢酶(LDH)、骨髓浸润、结外侵犯、浆膜腔积液、巨大肿块、CD20高表达相关(P<0.05),CA125增高者化疗完全缓解率(CR)低,且容易复发(P<0.05)。结论血清CA125水平与淋巴瘤细胞浸润有一定相关性,可作为NHL患者诊断、病情进展及复发预测又一重要的辅助指标。 Objective To investigate the correlations between serum CA125 level and infiltration of lymphoma cells and response to treatment in patients with non Hodgkin's lymphoma(NHL). Methods Ser um CA125 levels in 103 patients with NHL were measured by radioimmunoassay (RIA), and the associations between CA125 levels and other presenting features were examined. Results CA125 levels were elevated in 49. 5% of patients with NHL. A higher CA125 level was associated with high serum lactate dehydrogenase level, bone marrow involvement, extranodal involvement, and effusions, bulky disease and high expression of CD20(P〈0. 05). Complete responses were higher in patients with normal CA125 lev els than in patients with elevated CA125 levels, and the latter patients were apt to recurrence. Conclusion There are some correlations between serum CA125 level and infiltration peculiarity of lymphoma ceils. And serum CA125 can be taking as an important auxiliary index to diagnose, advanced disease and evaluation the effectiveness of treatment.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第9期659-661,共3页 Cancer Research on Prevention and Treatment
关键词 CA125 非霍奇金淋巴瘤 浸润 疗效 CA125 NHL Infiltration Response to treatment
  • 相关文献

参考文献10

  • 1刘瑶,陈红,黄晓东,余志慧,王晓晖.卵巢癌患者CA125表达和免疫状态关系研究[J].肿瘤防治研究,2005,32(5):290-292. 被引量:6
  • 2Lazzarino M, Orlandi E, Klersy C, et al. Serum CA125 is of clinical value in the staging and follow up of patients with non Hodgkin's lymphoma: correlation with tumor parameters and disease activity[J]. Caflcer, 1998,82 (3) : 576-582.
  • 3Benboubker L, Valat C, Linassier C, et al. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels[J]. Annals of Oncology, 2000, 11(11):1485-1491.
  • 4Zacharos ID, Efstathiou SP, Petreli E, et al. The prognostic significance of CA125 in patients with non-Hodgkin's lymphoma [J]. Eur J Haematol, 2002,69 (4) : 221-226.
  • 5Zidan J, Hussein O, Basher W, et al. Serum CA125: A Tumor Marker for Monitoring Response to Treatment and Follow up in Patients wilh Non-Hodgkin's Lyrnphorna[J]. The Oncologist,2004,9(4) :417 421.
  • 6Gui W, Zheng YP,Wang J, et al. CA125 expression in patients with non-Hodgkin's lymphoma[J]. Leuk Lymphoma, 2006,47 (7) : 1322-1326.
  • 7Bonnet C, Beguin Y, Fassotte MF, et al. Limited usefulness of CA125 measurement in the management of Hodgkin's and non- Hodgkin's lymphoma[J]. Eur J Haematol, 2007, 78 (5) : 399- 404.
  • 8邱立华,姜之馨,魏熙胤,牛瑞芳,王慧君,佟仲生,李凯,王华庆.非霍奇金淋巴瘤骨髓受累的免疫表型探讨[J].中国肿瘤临床,2006,33(7):391-394. 被引量:3
  • 9Vlasveld LT, Emens AA, Sonnenbemg AA, et al. Elevated serum CA 125 concentrations due to expression by a diffuse large B-cell lymphoma[J]. Ann Clin Biochem, 2000,37( Pt 4) :545- 548.
  • 10Pabst T, Ludwig C. CA125:a tumor marker in non-Hodgkin's lymphomas? [J]. J Clin Oncol, 1995,13 (13) : 1827-1828.

二级参考文献11

共引文献7

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部